Kyowa Kirin

News

GSK's kidney disease anaemia drug approved in Japan, taking ...

GlaxoSmithKline’s drug for anaemia caused by chronic kidney disease daprodustat has been approved in Japan, taking on a recently approved rival from Astellas.

News

FDA approves Kyowa Kirin's new Parkinson's drug Nourianz

The FDA has approved a new drug for Parkinson’s disease, giving the nod to Kyowa Kirin’s Nourianz (istadefylline) as an add-on to dopamine replacement drugs to reduce “off” episodes when th

News

Could Kyowa Kirin be eyeing ophthalmology use for cancer dru...

Kyowa Kirin has bought back rights outside of cancer to tivozanib, amending an agreement dating back to 2006 with AVEO, and opening up the possibility of research in ophthalmology.

News

EU approves Kyowa Kirin's drug for rare lymphoma

The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma.

News

NHS saving £300m with Humira biosimilar deal

The NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of AbbVie’s Humira inflammatory diseases drug.

News

NICE backs funding for Kyowa Kirin's bone disorder drug

Children in England and Wales with a rare inherited disorder causing soft and weak bones can have access to a new therapy after NICE said Kyowa Kirin’s Crysvita can receive regular NHS fund

GSK's kidney disease anaemia drug approved in Japan, taking ...

FDA approves Kyowa Kirin's new Parkinson's drug Nourianz

Could Kyowa Kirin be eyeing ophthalmology use for cancer dru...

EU approves Kyowa Kirin's drug for rare lymphoma

NHS saving £300m with Humira biosimilar deal

NICE backs funding for Kyowa Kirin's bone disorder drug

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

Kyowa Kirin

Editor's Picks